iifl-logo

Vista Pharmaceuticals Ltd Share Price

10.04
(-3.46%)
May 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open10.74
  • Day's High10.74
  • 52 Wk High16.59
  • Prev. Close10.4
  • Day's Low9.93
  • 52 Wk Low 9.1
  • Turnover (lac)0.16
  • P/E0
  • Face Value2
  • Book Value11.25
  • EPS0
  • Mkt. Cap (Cr.)38.98
  • Div. Yield0
View All Historical Data
No Records Found

Vista Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

10.74

Prev. Close

10.4

Turnover(Lac.)

0.16

Day's High

10.74

Day's Low

9.93

52 Week's High

16.59

52 Week's Low

9.1

Book Value

11.25

Face Value

2

Mkt Cap (₹ Cr.)

38.98

P/E

0

EPS

0

Divi. Yield

0

Vista Pharmaceuticals Ltd Corporate Action

8 Sep 2024

12:00 AM

AGM

Announcement Date: 08 Sep, 2024

arrow

19 Sep 2024

12:00 AM

BookCloser

arrow

14 Feb 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

19 Feb 2025

12:00 AM

EGM

arrow

Vista Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Vista Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

09 May, 2025|01:22 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 9.27%

Foreign: 9.27%

Indian: 11.90%

Non-Promoter- 0.03%

Institutions: 0.02%

Non-Institutions: 78.79%

Custodian: 0.00%

Share Price

Vista Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

14.24

13.67

7.36

7.36

Preference Capital

0

0

0

0

Reserves

26.22

23.04

28.09

25.49

Net Worth

40.46

36.71

35.45

32.85

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Revenue

1.26

22.75

31.07

28.91

yoy growth (%)

-94.43

-26.75

7.45

19.58

Raw materials

-0.73

-23.93

-25.41

-15.96

As % of sales

57.65

105.17

81.78

55.2

Employee costs

-1.15

-1.48

-1.36

-1.05

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2019Mar-2018

Profit before tax

-3.68

-3.93

1.14

2.82

Depreciation

-0.72

-1.34

-1.36

-1.33

Tax paid

1.8

0.25

-0.2

-0.64

Working capital

-7.21

-2.48

-0.12

5.94

Other operating items

View Cash Flow
Y/e 31 MarMar-2021Mar-2020Mar-2019Mar-2018

Growth matrix (%)

Revenue growth

-94.43

-26.75

7.45

19.58

Op profit growth

-63.94

-488

-76.84

74.74

EBIT growth

-10.72

-184.93

-35.91

109.75

Net profit growth

-48.73

-491.44

-57.03

75.27

View Ratios

No Record Found

Vista Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,744.85

132.894,18,647.961,181.050.775,985.3398.33

Divis Laboratories Ltd

DIVISLAB

6,001.1

76.851,59,310.355940.52,297513.62

Cipla Ltd

CIPLA

1,478.5

25.661,19,409.631,438.150.884,134.87360.72

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,137.55

58.211,06,184.184850.892,330222.38

Mankind Pharma Ltd

MANKIND

2,413.35

51.4999,569.64416.3802,396.57334.17

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Vista Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Chairman & Wholetime Director

Dhananjaya Alli

Non-Exec & Non-Independent Dir

M H Rao

Non-Exec & Non-Independent Dir

Stanley Prabhakar Reddy

Non-Exec. & Independent Dir.

Umesh V Banakar

Non-Exec. & Independent Dir.

Chakravarthula Divya Bhavani

Non Executive Director

Umakanth Katta

Non Executive Director

Divakar Reddy Yerrabommanahalli

Managing Director

Murali Meraga

Whole Time Director

Pavan Sathvik Gilaka

Company Sec. & Compli. Officer

Barkha Jain

Non-Exec. & Independent Dir.

Naga Raja Madineni

Non-Exec. & Independent Dir.

Madhu Sudan Anchi

Non-Exec. & Independent Dir.

Swapna Priya Gunduboina

Non-Exec. & Independent Dir.

Anumala Ravi Chandra Kumar

Non-Exec. & Independent Dir.

Rama Mohan Manamasa

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Vista Pharmaceuticals Limited was incorporated on January 25,1991 with the Registrar of Companies, Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. The Company is engaged in the formulation of pharmaceutical products. It offers a range of products mainly into the therapeutic areas of gastrointestinal, pain management and anti-infection, catering to common ailments. This division is a primary contributor to the domestic sales of Torrent Pharmaceuticals Ltd., based in Hyderabad, India.The Company was in process of setting up a 100% EOU for manufacture of drug formulations with an installed capacity of 400 million tablets & 200 million capsules per annum. Apart from these, the Company offers over the counter & prescription generic drug products consisting of tablets, capsules and liquids covering various therapeutic categories. The Company was founded in 1992 to Formulate, Register, Produce, Market and Distribute High Quality Pharmaceutical Products, initially focusing on the United States Market of expanding Globally. It is the first Indian Company to obtain USFDA Approvals to produce OTC as well as Prescription Drugs to US Market in 1994. It is the first Indian Company to export OTC as well as Prescription Drugs to US in 1996. The Companys Indian Facility got USFDA Approval in June 2010 to produce ANDA products to US Market. It established an extensive Marketing and Distribution Network in the United States. The Company operations ar
Read More

Company FAQs

What is the Vista Pharmaceuticals Ltd share price today?

The Vista Pharmaceuticals Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is ₹10.04 today.

What is the Market Cap of Vista Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Vista Pharmaceuticals Ltd is ₹38.98 Cr. as of 09 May ‘25

What is the PE and PB ratio of Vista Pharmaceuticals Ltd?

The PE and PB ratios of Vista Pharmaceuticals Ltd is 0 and 0.92 as of 09 May ‘25

What is the 52 Week High and Low of Vista Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Vista Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Vista Pharmaceuticals Ltd is ₹9.1 and ₹16.59 as of 09 May ‘25

What is the CAGR of Vista Pharmaceuticals Ltd?

Vista Pharmaceuticals Ltd's CAGR for 5 Years at 6.90%, 3 Years at 5.73%, 1 Year at -27.02%, 6 Month at -17.00%, 3 Month at -4.06% and 1 Month at -11.94%.

What is the shareholding pattern of Vista Pharmaceuticals Ltd?

The shareholding pattern of Vista Pharmaceuticals Ltd is as follows:
Promoters - 21.19 %
Institutions - 0.02 %
Public - 78.79 %

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.